GI Symptoms in Infants Fed GMF or CMF

April 30, 2024 updated by: Ausnutria Hyproca B.V.

Common Gastrointestinal Symptoms in Healthy Infants Receiving Goat Milk-based Formula or Cow Milk-based Formula: a Double-blind, Randomized Controlled Trial

The aim of this study was to assess common gastrointestinal symptoms in healthy Brazilian infants receiving goat milk-based infant formula (GMF) compared to cow's milk-based infant formula (CMF) during a 24 week intervention.

Study Overview

Detailed Description

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this double-blind, randomized controlled trial, gastrointestinal comfort in infants fed goat milk-based infant formula (GMF) or cow's milk-based infant formula (CMF) was studied.

Fifty-six healthy infants aged 3-12 months were followed for 24 weeks. Stool consistency, regurgitation frequency and crying duration were measured weekly using an adapted version of the Cow's Milk-related Symptom Score (CoMiSS®) where only the items for these scores were used. Blood hemoglobin levels were measured at the start and at the end of the intervention.

Study Type

Interventional

Enrollment (Actual)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bahia
      • Salvador, Bahia, Brazil
        • Daycare center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • gestational age 37-42 weeks
  • 3-12 months old at enrollment
  • should have consumed cow's milk-based products during the 48 hours prior to the baseline visit to exclude cow's milk allergic infants

Exclusion Criteria:

  • metabolic or chronic disease or congenital malformation, serious concurrent illness that would interfere with study treatment, (i.e. sepsis, pneumonia with respiratory failure, cardiac failure)
  • infant's parent(s) or primary caregiver(s) diagnosed with major depression
  • infant's weight for length at baseline >|3| z-score indexes according to WHO criteria
  • infants enrolled in another interventional clinical research study
  • infants diagnosed with cow's milk allergies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Goat milk-based infant formula
Experimental group receives goat milk-based formula for 24 weeks
Goat milk-based infant formula fed at age appropriate quantities for 24 weeks
Active Comparator: Cow's milk-based infant formula
Control group receives cow's milk-based formula for 24 weeks
Cow's milk-based infant formula formula fed at age appropriate quantities for 24 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal symptoms
Time Frame: 24 weeks, measured weekly
Stool consistency, regurgitation frequency and crying duration as measured by an adapted Cow's Milk-related Symptom Score®, where a higher score indicates more severe symptoms.
24 weeks, measured weekly

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood hemoglobin levels
Time Frame: 24 weeks, measured at start and end
Blood hemoglobin levels before and after intervention
24 weeks, measured at start and end
WHO z-score of weight-for-age
Time Frame: 24 weeks, measured monthly
Weight measured to the nearest 5.0 grams with clothes and diaper removed.
24 weeks, measured monthly
WHO z-score of length-for-age
Time Frame: 24 weeks, measured monthly
Body length without shoes, measured lying down to the nearest centimeter with a neonatometer.
24 weeks, measured monthly
WHO z-score of head circumference-for-age
Time Frame: 24 weeks, measured monthly
Head circumference measured with flexible non-stretching tape to the nearest centimeter.
24 weeks, measured monthly
WHO z-score of weight-for-length
Time Frame: 24 weeks, measured monthly
Weight and length measured as described above combined.
24 weeks, measured monthly

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hugo da Costa Ribeiro, Dr., Hospital Professor Edgard Santos, Federal University of Bahia, Salvador, Brazil

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2019

Primary Completion (Actual)

October 6, 2019

Study Completion (Actual)

October 6, 2019

Study Registration Dates

First Submitted

April 26, 2024

First Submitted That Met QC Criteria

April 30, 2024

First Posted (Actual)

May 2, 2024

Study Record Updates

Last Update Posted (Actual)

May 2, 2024

Last Update Submitted That Met QC Criteria

April 30, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Diseases

Clinical Trials on Goat milk-based infant formula

Subscribe